Estimating the need for radiotherapy for lung cancer: an evidence-based, epidemiologic approach (Q34175790)

31 July 2017

1 reference

title

Estimating the need for radiotherapy for lung cancer: an evidence-based, epidemiologic approach (English)

1 reference

adaptive radiation therapy

31 July 2017

main subject

0 references

1 reference

1 reference

Tyldesley S

1

1 reference

31 July 2017

Boyd C

2

1 reference

31 July 2017

Schulze K

3

1 reference

31 July 2017

Walker H

4

1 reference

31 July 2017

Mackillop WJ

5

1 reference

31 July 2017

language of work or name

English

0 references

publication date

1 March 2001

1 reference

International Journal of Radiation Oncology Biology Physics

31 July 2017

published in

1 reference

31 July 2017

volume

49

1 reference

31 July 2017

issue

4

1 reference

31 July 2017

page(s)

973-985

1 reference

Radiotherapy in Sweden--a study of present use in relation to the literature and an estimate of future trends

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901401-2

7 January 2021

Does a centralized radiotherapy system provide adequate access to care?

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901401-2

7 January 2021

Variations in the management and outcome of non-small cell lung cancer in Ontario

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901401-2

7 January 2021

How do we bring an acceptable level of radiotherapy services to a dispersed population?

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901401-2

7 January 2021

Resources and productivity in radiation oncology in Denmark, Finland, Iceland, Norway and Sweden during 1987.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901401-2

7 January 2021

Limitations of epidemiologically based needs assessment. The case of prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901401-2

7 January 2021

Rules of evidence and clinical recommendations on the use of antithrombotic agents

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901401-2

7 January 2021

Generalizability of the surveillance, epidemiology, and end results registry population: factors relevant to epidemiologic and health care research

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901401-2

7 January 2021

The National Cancer Data Base report on lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901401-2

7 January 2021

Age and the treatment of lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901401-2

7 January 2021

A randomized trial of the four most active regimens for metastatic non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901401-2

7 January 2021

Chemotherapy can prolong survival in patients with advanced non-small-cell lung cancer--report of a Canadian multicenter randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901401-2

7 January 2021

Prospective evaluation of a watch policy in patients with inoperable non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901401-2

7 January 2021

A needs-based methodology for allocating health care resources in Ontario, Canada: development and an application

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901401-2

7 January 2021

Importance of timing for thoracic irradiation in the combined modality treatment of limited-stage small-cell lung cancer. The National Cancer Institute of Canada Clinical Trials Group

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901401-2

7 January 2021

A randomized comparison of standard chemotherapy versus alternating chemotherapy and maintenance versus no maintenance therapy for extensive-stage small-cell lung cancer: a phase III study of the Eastern Cooperative Oncology Group

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901401-2

7 January 2021

Superiority of alternating non-cross-resistant chemotherapy in extensive small cell lung cancer. A multicenter, randomized clinical trial by the National Cancer Institute of Canada

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901401-2

7 January 2021

Randomized study of cyclophosphamide, doxorubicin, and vincristine versus etoposide and cisplatin versus alternation of these two regimens in extensive small-cell lung cancer: a phase III trial of the Southeastern Cancer Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901401-2

7 January 2021

Significance of extramucosal residual tumor at the bronchial resection margin

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901401-2

7 January 2021

[Incomplete resections in bronchial carcinoma: morbidity and prognosis]

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901401-2

7 January 2021

Chest wall invasive non-small cell lung cancer: patterns of failure and implications for a revised staging system

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901401-2

7 January 2021

Neoadjuvant therapy: a novel and effective treatment for stage IIIb non-small cell lung cancer. Southwest Oncology Group

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901401-2

7 January 2021

Trading treatment toxicity for survival in locally advanced non-small cell lung cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901401-2

7 January 2021

Chemotherapy versus chemotherapy plus irradiation in limited small cell lung cancer. Results of a controlled trial with 5 years follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901401-2

7 January 2021

Radiotherapy in small cell cancer of the lung treated with combination chemotherapy: a controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901401-2

7 January 2021

Prospective randomized comparison of high-dose and standard-dose etoposide and cisplatin chemotherapy in patients with extensive-stage small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901401-2

7 January 2021

A randomized trial of anticoagulation with warfarin and of alternating chemotherapy in extensive small-cell lung cancer by the Cancer and Leukemia Group B.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901401-2

7 January 2021

Postoperative radiation therapy in lung caner: a controlled trial after resection of curative design

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901401-2

7 January 2021

The role of post-operative radiotherapy in non-small-cell lung cancer: a multicentre randomised trial in patients with pathologically staged T1-2, N1-2, M0 disease. Medical Research Council Lung Cancer Working Party

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901401-2

7 January 2021

Effects of postoperative mediastinal radiation on completely resected stage II and stage III epidermoid cancer of the lung

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901401-2

7 January 2021

10.1016/S0360-3016(00)01401-2

Identifiers

DOI

1 reference

31 July 2017

1 reference